In the BioHarmony Drug Report Database

"Preview" Icon

Nafarelin

Synarel (nafarelin) is a protein pharmaceutical. Nafarelin was first approved as Synarel on 1990-02-13. It is used to treat endometriosis and precocious puberty in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor.

 

Trade Name

 

Synarel
 

Common Name

 

nafarelin
 

ChEMBL ID

 

CHEMBL1201309
 

Indication

 

endometriosis, precocious puberty
 

Drug Class

 

Prehormones or hormone-release stimulating peptides

Image (chem structure or protein)

Nafarelin structure rendering